SPC469

Zilucoplan

  • Status:
    Veitt
  • Application date:
    30.5.2024
  • Application published:
    15.6.2024
  • Grant published:
    15.12.2025
  • Max expiry date:
    3.12.2038
  • Medicine name:
    Zilbrysq
  • Medicine for children:
    No

Timeline

Today
30.5.2024Application
15.6.2024Publication
15.12.2025Registration
3.12.2038Expires

Marketing license

  • IS authorization number:
    EU/1/23/1764
  • Date:
    15.12.2023
  • Foreign authorization number:
    EU/1/23/1764
  • Date:
    1.12.2023

Owner

  • Name:
    UCB Holdings, Inc.
  • Address:
    1950 Lake Park Drive, Smyrna, GA 30080 US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 22.11.2025

Upload documents